CEO at VeraMorph
VeraMorph
The startup specializes in oral drug delivery technology that utilizes proprietary hydrogel tablets to enhance drug stability and dissolution rates. This technology enables pharmaceutical companies to achieve higher drug loading and maintain prolonged saturation levels, ultimately reducing the time and cost associated with bringing products to market.
- Biotechnology
Updated 21 months ago
Funding
Raised to date
$260KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup specializes in oral drug delivery technology that utilizes proprietary hydrogel tablets to enhance drug stability and dissolution rates. This technology enables pharmaceutical companies to achieve higher drug loading and maintain prolonged saturation levels, ultimately reducing the time and cost associated with bringing products to market.